Finasteride Polymeric Nanocapsules for Alopecia Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for alopecia, particularly androgenetic alopecia, face challenges with the stability, bioavailability, and formulation of finasteride, leading to inadequate penetration and retention of the drug at the hair follicle site, resulting in suboptimal hair growth outcomes.
Innovation Solution
The development of polymeric nanocapsules containing finasteride, formed using a hydrophobic polymer like poly(ε-caprolactone), a mixture of oils, and a low HLB surfactant, which are stabilized in an aqueous phase with polysorbate 80, allowing for enhanced encapsulation and topical delivery directly to the hair follicles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If finasteride is formulated in traditional topical preparations, then the formulation is simple to prepare, but the drug stability and bioavailability are insufficient
Solution Approach 1:
The patent changes the physical and chemical parameters of finasteride by encapsulating it in polymeric nanocapsules. This transforms the drug from a conventional topical formulation into a nanoparticulate system with controlled size (10-100 nm), improved stability, and enhanced bioavailability. The polymeric matrix provides protection against degradation while maintaining drug efficacy.
Solution Approach 2:
The patent employs composite material structure by combining finasteride with biodegradable polymeric materials to form nanocapsules. This composite approach integrates the therapeutic benefits of finasteride with the protective and delivery advantages of polymeric nanocarriers, achieving both stability and controlled release.
2Quantity of substance
If finasteride is applied topically in conventional formulations, then the application method is simple, but the penetration and retention at the hair follicle site are inadequate
Solution Approach 1:
The patent segments the finasteride drug into individual nanocapsule units with size 10-100 nm. This segmentation enables the drug to penetrate the hair follicle structure more effectively and be retained at the target site, as the nanoscale particles can navigate biological barriers more efficiently than conventional formulations.
Solution Approach 2:
The polymeric nanocapsules act as intermediaries that facilitate the delivery of finasteride to the hair follicle site. These nanocapsules serve as carrier vehicles that protect the drug during transit and enable targeted delivery, improving both penetration and retention at the action site.
3Productivity
If finasteride is used to treat androgenetic alopecia, then the treatment targets the correct condition, but the hair growth outcome is suboptimal due to inadequate drug delivery
Solution Approach 1:
The patent changes the delivery parameters by using nanocapsules with specific size range (10-100 nm) and polymeric composition. This enables controlled release kinetics and improved drug concentration at the hair follicle, directly enhancing hair growth outcomes while maintaining targeted treatment of androgenetic alopecia.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanocapsule formulation achieves improved stability and increased bioavailability of finasteride, leading to accelerated hair growth and increased mature follicle development, outperforming traditional formulations in in vivo studies by effectively targeting androgenetic alopecia.
Implementation Method 1
polymeric nanocapsules containing finasteride, formed using a hydrophobic polymer like poly(ε-caprolactone)
Implementation Method 2
a low HLB surfactant, which are stabilized in an aqueous phase with polysorbate 80
Data Source
Figure 1~2
Figure 3A~3D
Figure 4A~5
AI summary
The present invention aims to provide a pharmaceutical composition for the treatment of alopecia, said composition comprising polymeric nanoparticles, preferably nanocapsules, containing finasteride, additives and a pharmaceutically acceptable carrier, as well as the use of the nanoparticles for preparing said composition for treating alopecia. The invention further includes an appropriate finasteride nanocapsule preparation process suitable for a composition for topical application for treating alopecia.